1. Home
  2. STAA vs COLL Comparison

STAA vs COLL Comparison

Compare STAA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • COLL
  • Stock Information
  • Founded
  • STAA 1982
  • COLL 2002
  • Country
  • STAA United States
  • COLL United States
  • Employees
  • STAA 1211
  • COLL N/A
  • Industry
  • STAA Ophthalmic Goods
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • STAA Health Care
  • COLL Health Care
  • Exchange
  • STAA Nasdaq
  • COLL Nasdaq
  • Market Cap
  • STAA 850.9M
  • COLL 958.8M
  • IPO Year
  • STAA N/A
  • COLL 2015
  • Fundamental
  • Price
  • STAA $17.07
  • COLL $30.30
  • Analyst Decision
  • STAA Hold
  • COLL Strong Buy
  • Analyst Count
  • STAA 8
  • COLL 4
  • Target Price
  • STAA $27.17
  • COLL $43.75
  • AVG Volume (30 Days)
  • STAA 817.0K
  • COLL 290.8K
  • Earning Date
  • STAA 08-06-2025
  • COLL 08-07-2025
  • Dividend Yield
  • STAA N/A
  • COLL N/A
  • EPS Growth
  • STAA N/A
  • COLL N/A
  • EPS
  • STAA N/A
  • COLL 1.25
  • Revenue
  • STAA $279,134,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • STAA N/A
  • COLL $20.04
  • Revenue Next Year
  • STAA $29.34
  • COLL $3.98
  • P/E Ratio
  • STAA N/A
  • COLL $24.22
  • Revenue Growth
  • STAA N/A
  • COLL 17.17
  • 52 Week Low
  • STAA $13.50
  • COLL $23.23
  • 52 Week High
  • STAA $49.86
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • STAA 43.92
  • COLL 58.69
  • Support Level
  • STAA $16.53
  • COLL $29.28
  • Resistance Level
  • STAA $17.31
  • COLL $30.17
  • Average True Range (ATR)
  • STAA 0.63
  • COLL 0.75
  • MACD
  • STAA 0.01
  • COLL -0.02
  • Stochastic Oscillator
  • STAA 22.30
  • COLL 69.71

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: